User profiles for Sophie G Kellaway

Sophie Kellaway

Assistant Professor, University of Nottingham
Verified email at nottingham.ac.uk
Cited by 121

[PDF][PDF] Gene regulatory network analysis predicts cooperating transcription factor regulons required for FLT3-ITD+ AML growth

…, PS Chin, H Blair, L Ames, SG Kellaway… - Cell reports, 2023 - cell.com
Acute myeloid leukemia (AML) is a heterogeneous disease caused by different mutations.
Previously, we showed that each mutational subtype develops its specific gene regulatory …

PLCG1 is required for AML1-ETO leukemia stem cell self-renewal

…, YT Dai, Z Chen, SJ Chen, SG Kellaway… - Blood, The Journal …, 2022 - ashpublications.org
In an effort to identify novel drugs targeting fusion-oncogene–induced acute myeloid leukemia
(AML), we performed high-resolution proteomic analysis. In AML1-ETO (AE)-driven AML, …

Epigenetic regulator genes direct lineage switching in MLL/AF4 leukemia

…, SA Assi, M Ashtiani, SG Kellaway… - Blood, The Journal …, 2022 - ashpublications.org
The fusion gene MLL/AF4 defines a high-risk subtype of pro-B acute lymphoblastic leukemia.
Relapse can be associated with a lineage switch from acute lymphoblastic to acute …

[HTML][HTML] Leukemic stem cells activate lineage inappropriate signalling pathways to promote their growth

SG Kellaway, S Potluri, P Keane, HJ Blair… - Nature …, 2024 - nature.com
Acute Myeloid Leukemia (AML) is caused by multiple mutations which dysregulate growth
and differentiation of myeloid cells. Cells adopt different gene regulatory networks specific to …

[HTML][HTML] Identification and interrogation of the gene regulatory network of CEBPA-double mutant acute myeloid leukemia

…, P Chin, P Keane, SA Assi, S Potluri, SG Kellaway… - Leukemia, 2023 - nature.com
Acute myeloid leukemia (AML) is a heterogeneous hematological malignancy caused by
mutations in genes encoding transcriptional and epigenetic regulators together with signaling …

Different mutant RUNX1 oncoproteins program alternate haematopoietic differentiation trajectories

SG Kellaway, P Keane, B Edginton-White… - Life Science …, 2021 - life-science-alliance.org
Mutations of the haematopoietic master regulator RUNX1 are associated with acute myeloid
leukaemia, familial platelet disorder and other haematological malignancies whose …

[HTML][HTML] Molecular basis of hematological disease caused by inherited or acquired RUNX1 mutations

SG Kellaway, DJL Coleman, PN Cockerill… - Experimental …, 2022 - Elsevier
Highlights • Germline and acquired RUNX1 mutations are associated with FPD and MDS/AML.
• Large deletions and nonsense mutations are more common in germline FPD patients. • …

[HTML][HTML] RUNX1-EVI1 disrupts lineage determination and the cell cycle by interfering with RUNX1 and EVI1 driven gene regulatory networks

SG Kellaway, P Keane, E Kennett, C Bonifer - haematologica, 2021 - ncbi.nlm.nih.gov
Hematological malignancies are characterized by a block in differentiation, which in many
cases is caused by recurrent mutations affecting the activity of hematopoietic transcription …

[HTML][HTML] Gene regulation in t (6; 9) DEK:: NUP214 Acute Myeloid Leukemia resembles that of FLT3-ITD/NPM1 Acute Myeloid Leukemia but with an altered HOX/MEIS …

S Potluri, SG Kellaway, DJL Coleman, P Keane… - Leukemia, 2024 - nature.com
Acute Myeloid Leukemia (AML) represents a heterogeneous group of hematological
malignancies. The t (6; 9)(p23; q34) translocation, generating the DEK:: NUP214 fusion protein is …

Leukemic stem cells hijack lineage inappropriate signalling pathways to promote their growth

SG Kellaway, S Potluri, P Keane, HJ Blair, PS Chin… - bioRxiv, 2023 - biorxiv.org
Acute Myeloid Leukemia (AML) is caused by multiple mutations which dysregulate growth
and differentiation of myeloid cells. Cells adopt different gene regulatory networks specific to …